Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: JAMA Pediatr. 2016 Jun 1;170(6):585–592. doi: 10.1001/jamapediatrics.2016.0097

Table 3.

HRs of Childhood Cancer Among Children Age 5 Years and Younger by Mother’s Ethnicity and Birthplacea

Cancer Type US-Born White Mothers (n = 4368)
US-Born Hispanic Mothers (n = 2320)
Non-US–Born Hispanic Mothers (n = 3798)
No. (%) No. (%) Adjusted HR (95% CI) No. (%) Adjusted HR (95% CI)
Acute lymphoblastic leukemia 1204 (36.9) 748 (22.9) 1.20 (1.10–1.32) 1314 (40.2) 1.06 (0.98–1.15)

Acute myeloid leukemia 200 (36.6) 132 (24.2) 1.28 (1.02–1.61) 214 (39.2) 1.05 (0.87–1.28)

Hodgkin lymphoma 13 (19.7) 19 (28.8) 2.49 (1.21–5.13) 34 (51.5) 2.35 (1.24–4.47)

Non-Hodgkin lymphoma 56 (45.5) 23 (18.7) 0.79 (0.48–1.30) 44 (35.8) 0.76 (0.51–1.14)

Burkitt lymphoma 46 (48.4) 15 (15.8) 0.69 (0.38–1.25) 34 (35.8) 0.73 (0.47–1.15)

Ependymoma 93 (43.5) 58 (27.1) 1.24 (0.88–1.74) 63 (29.4) 0.68 (0.49–0.93)

Glioma 629 (53.2) 231 (19.5) 0.71 (0.61–0.83) 323 (27.3) 0.50 (0.44–0.58)

 High grade 58 (53.2) 20 (18.3) 0.58 (0.34–0.97) 31 (28.4) 0.49 (0.32–0.77)

 Low grade 165 (53.4) 49 (15.9) 0.61 (0.44–0.85) 95 (30.7) 0.58 (0.45–0.75)

Astrocytoma 442 (56.5) 143 (18.3) 0.62 (0.51–0.75) 197 (25.2) 0.43 (0.36–0.51)

Intracranial and intraspinal embryonal tumors 250 (45.0) 118 (21.3) 0.85 (0.68–1.07) 187 (33.7) 0.71 (0.59–0.86)

 PNET 96 (40.9) 50 (21.3) 0.86 (0.61–1.23) 89 (37.9) 0.86 (0.64–1.14)

 Medulloblastoma 101 (47.9) 43 (20.4) 0.78 (0.54–1.13) 67 (31.8) 0.63 (0.46–0.86)

Neuroblastoma 569 (54.0) 206 (19.5) 0.66 (0.56–0.78) 279 (26.5) 0.47 (0.40–0.54)

Retinoblastoma 213 (37.8) 133 (23.6) 1.14 (0.91–1.42) 217 (38.5) 0.97 (0.80–1.18)

 Unilateral 142 (37.2) 99 (25.9) 1.27 (0.97–1.65) 141 (36.9) 0.94 (0.74–1.19)

 Bilateral 71 (40.1) 33 (18.6) 0.83 (0.54–1.28) 73 (41.2) 0.99 (0.72–1.38)

Wilms tumor 369 (45.8) 171 (21.2) 0.88 (0.73–1.06) 266 (33.0) 0.70 (0.59–0.82)

Hepatoblastoma 100 (36.8) 61 (22.4) 1.16 (0.83–1.61) 111 (40.8) 1.09 (0.83–1.44)

Bone tumors 37 (44.0) 27 (32.1) 1.38 (0.83–2.31) 20 (23.8) 0.50 (0.29–0.87)

 Ewings sarcoma 22 (45.8) 14 (29.2) 1.23 (0.61–2.46) 12 (25.0) 0.52 (0.26–1.06)

Soft-tissue sarcomas 209 (40.7) 115 (22.4) 1.05 (0.83–1.32) 189 (36.8) 0.87 (0.71–1.06)

 Rhabdomyosarcoma 142 (42.4) 71 (21.2) 0.97 (0.72–1.30) 122 (36.4) 0.83 (0.65–1.06)

Germ-cell tumors 126 (39.5) 61 (19.1) 0.81 (0.59–1.11) 132 (41.4) 0.97 (0.76–1.24)

 Yolk sac tumors 44 (33.8) 23 (17.7) 0.82 (0.49–1.38) 63 (48.5) 1.29 (0.88–1.91)

 Teratoma 58 (40.0) 33 (22.8) 0.95 (0.61–1.47) 54 (37.2) 0.85 (0.59–1.24)

Abbreviations: HR, hazard ratio; PNET, primitive neuroectodermal tumor.

a

Adjusted models control for maternal and paternal ages.